fashion -WSS

fashion

author：explore 2025-10-01 23:02:51 - browse：21915

Treeline Northwest — AP Photo/Ted S. Warren

Josh Bilenker’s last company, Loxo Oncology, was purchased by Eli Lilly for $8 billion. No surprise, then, that his next effort has already raised at least $473 million in funding from private investors even before telling the public what, exactly, it is working on.

Treeline Biosciences, the new venture by Bilenker and Jeffrey Engelman, formerly Novartis’s top cancer researcher, has hired more than 130 people across three research sites in little more than a year, according to a company blog post, regulatory filings, and STAT reporting.

Treeline’s website doesn’t mention a single drug target or disease. In a paper published last year in Nature Cancer, Engelman and several colleagues reviewed the history of a class of cancer drugs called PI3 kinase inhibitors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： A preacher's new calling: Diversifying neuroscience research

WSS

Physician assistants need a new name. Here's what it should be

PhRMA lawsuit over Medicare drug price negotiation tossed

FDA early review: GLP

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Male doctors called my cancer incurable. A female doctor showed it wasn't

Arena BioWorks launches in Cambridge to speed drug discovery

focus

fashion

hotspot

The high cost of giving birth even with insurance

Fauci's latest grilling in Congress: 9 hours, behind closed doors

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

After affirmative action ruling, medical educators look to 'holistic review'

Medicare Advantage coverage denials need scrutiny, senators say

23andMe had bad news about my health. I wish a person had delivered it

Robert F. Kennedy is pitching centrism on health, even on abortion

Psychedelics group wrestles with new pharma identity

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

Wikipedia

Biden report: The neurospychology of memory and aging

Doctors' information doesn't help them choose wisely when sick

To avoid data mishandling cases, universities eye AI and other tools

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Physician assistants need a new name. Here's what it should be

explore

focus

Wikipedia

leisure time